Abiopharma

VERISK ANALYTICS, INC. (VRSK) Reports the reporting period Financial Results VERISK ANALYTICS, INC. (VRSK) announced its financial results for the period ending the reporting period. Key Financial Highlights:

• Revenue: 3190
• Net Income: 1.73
• EPS: 1.82
• Cash and equivalents: $390 million
  • 5787 for U.S. participants, 1
  • 4048 for Canada participants, or 1
  • 8935 for U.K. participants. A replay of the webcast will be available for up to 1 year on our investor website. About Verisk Verisk (Nasdaq: VRSK) is a leading strategic data analytics and technology partner to the global insurance industry. It empowers clients to strengthen operating efficiency, improve underwriting and claims outcomes, combat fraud and make informed decisions about global risks, including climate change, catastrophic events, sustainability and political issues. Through advanced data analytics, software, scientific research and deep industry knowledge, Verisk helps build global resilience for individuals, communities and businesses. With teams across more than 20 countries, Verisk consistently earns certification by Great Place to Work. Verisk is traded on the Nasdaq exchange and is a part of the S&P 500 Index and the Nasdaq